FDA Commissioner Marty Makary resigns after tumultuous tenure
FDA Commissioner Marty Makary has resigned after a tumultuous 13-month tenure, marked by increasing pressure from President Trump regarding his performance, particularly in the approval of flavored vapes and nicotine products.
WPN Brief
- What Happened
FDA Commissioner Marty Makary has resigned after a tumultuous 13-month tenure, marked by increasing pressure from President Trump regarding his performance, particularly in the approval of flavored vapes and nicotine products.
- Why It Matters
Makary's resignation reflects significant dissatisfaction within the Trump administration, highlighting the challenges faced by leadership in the FDA amid ongoing scrutiny over public health policies and product approvals.
- The Bigger Picture
This development underscores the broader tensions between regulatory agencies and political priorities, as well as the ongoing debates surrounding vaping regulations and public health, which have become increasingly contentious in recent years.
Related Reports
More coverage on this story
8 reports across the wire
Marty Makary resigns under pressure as head of the FDA
Marty Makary has resigned as the commissioner of the Food and Drug Administration (FDA) after just over a year in the role, amid increasing pressure from President Trump regarding his performance, particularly concerning the approval of flavored vapes and nicotine products. This resignation follows reports of dissatisfaction from Trump and ongoing scrutiny from various stakeholders.
FDA Commissioner Marty Makary is leaving his role, President Trump told reporters Tuesday, after Makary had battled officials in the health department and the White House on a range of policy issues
FDA Commissioner Marty Makary has announced his resignation after just over a year in the role, following significant pressure from President Trump regarding his performance, particularly in the approval of flavored vapes and nicotine products. This decision comes amid ongoing tensions between Makary and officials in the health department and the White House on various policy issues.
Marty Makary's tenure as head of FDA ends with 'difficulty'
FDA Commissioner Marty Makary has resigned after just over a year in office, following significant pressure from President Trump regarding his performance, particularly in the approval of flavored vapes and nicotine products. Trump's comments indicated that Makary had been experiencing 'difficulty' in his role, leading to speculation about his future at the agency.
Fourth high-profile Trump official is out as FDA chief resigns
The head of the US Food and Drug Administration (FDA), Marty Makary, has resigned following intense pressure from Donald Trump's allies, pharmaceutical companies, and anti-abortion groups, marking a significant shift in leadership amid ongoing controversies surrounding the agency's regulatory decisions.
U.S. FDA head Marty Makary resigning after 13 months
FDA Commissioner Marty Makary has announced his resignation after 13 months in the role, a decision confirmed by President Trump, who acknowledged Makary's challenges during his tenure. This resignation follows a period of increasing dissatisfaction from Trump regarding Makary's performance, particularly in the approval processes for flavored vapes and nicotine products.
Senior leaders in the White House concluded that FDA Commissioner Marty Makary was out of step with President Trump’s priorities
Senior leaders in the White House have determined that FDA Commissioner Marty Makary is misaligned with President Trump’s priorities, leading to significant tensions within the administration. This conclusion comes amid growing dissatisfaction regarding Makary's performance, particularly in relation to the approval of flavored vapes and nicotine products.
Trump's FDA boss resigning as admin taps next acting leader
FDA Commissioner Marty Makary has resigned after just over a year in his role, following significant clashes with the Trump administration, particularly regarding the approval of flavored vapes and the abortion drug mifepristone. His resignation comes amid increasing pressure from pro-life groups and dissatisfaction from President Trump about his performance.
Trump has signed off on a plan to fire FDA Commissioner Marty Makary, according to people familiar with the matter
President Trump has reportedly signed off on a plan to fire FDA Commissioner Marty Makary, following a series of frustrations regarding the agency's performance, particularly its slow approval processes for flavored vapes and nicotine products. This decision reflects ongoing tensions between Trump and Makary over regulatory issues.